The global biodefense market size was valued at US$ 16.31 billion in the year 2023 and is estimated to reach a revised size of US$ 32.99 billion by 2033. This market is projected to expand at a CAGR of 7.3% during the analysis period. Increasing demand for vaccines, drugs, and medical devices creates opportunities for companies to expand their businesses and penetrate new markets.
Biological terrorism involves the deliberate release of viruses, bacteria, and other harmful germs capable of spreading epidemics and causing death. It has a detrimental impact on the economy because of the damage it causes to human health and the drain on human resources. Therefore, developed countries undertake a variety of efforts, as well as preventive measures, to strengthen their defense against these attacks.
Various countries maintain a constant supply of vaccines and biothreat detection technology to ensure the safety of their citizens. Government initiatives like this may help to accelerate the growth of the biodefense industry. It is possible to use biological toxins or infectious agents with malicious intentions, such as killing or infecting humans, animals, or the environment or even provoking biological warfare. In addition to living organisms such as bacteria, viruses, fungi, and toxins, several agents are used in bioterrorism.
By deliberately infecting and killing people, these agents can be used to cause social and economic turmoil. As a result of government initiatives, and increased government attention and funding towards biodefense strategies, the biodefense market is fueled by various factors. For example, the Department of Defense is modernizing its approach to develop medical countermeasures to protect warfighters from novel biological agents.
In the years to come, the scope of the biodefense market may be further expanded by increasing private investment. This is due to the occurrence of different viruses such as the flu, the Ebola virus, and the Zika virus.
Some technological advancements have been made in genetic engineering and biotechnology in the past few years. These advancements have enabled innovative approaches to combat these deadly, naturally occurring viruses that can be redesigned to cause additional harm. Moreover, these organisms are readily available, making biodefense an imperative aspect of countries around the world. The use of various biological agents, such as botulism, anthrax, and chemical and nuclear agents, has contributed to severe destruction as a result of bioterrorism.
Attributes
Details
Biodefense Market Value (2023)
US$ 16.31 billion
Biodefense Market Expected Value (2033)
US$ 32.99 billion
Biodefense Market Projected CAGR (2023 to 2033)
7.3%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global Biodefense Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)
The global biodefense market expanded at 8.1% CAGR over the past 10 years. The market is anticipated to expand at a CAGR of close to 7.3% over the forthcoming decade.
Biodefense markets were positively impacted by the pandemic. As a result of the pandemic, numerous government and non-governmental agencies were required to coordinate their responses nationwide, as catastrophic biological events can result in significant human and economic losses. Since the pandemic promises huge potential for investment and income redistribution, there are many reasons to believe it is an intentional act of bioterrorism.
Short Term (2023 to 2026): As the market grows, it may provide new opportunities for companies developing and producing vaccines, diagnostics, and therapeutic products for the prevention and treatment of infectious diseases.
Medium Term (2026 to 2029): The market is driven by factors such as increasing government funding for research and development, growing concern over the threat of pandemics and bioterrorism, and advancements in biotechnology.
Long Term (2029 to 2033): The prominent advancement of biotechnology is leading to the development of new and more effective biodefense products, such as vaccines and diagnostic tests, providing opportunities for companies in the biodefense market.
Historical CAGR (2016 to 2022)
8.1%
Historical Market Value (2022)
US$ 15.20 billion
Forecast CAGR
7.3%
Comparative Analysis of Adjacent Biodefense Markets
Biodefense Market:
Differentiating Aspects
Biodefense Market
CAGR (2023 to 2033)
7.3%
Market Valuation in 2023
US$ 16.31 billion
Projected Market Value in 2033
US$ 32.99 billion
Growth Factors
Rising investment in research and development for biodefense.
Opportunities
Growing demand for vaccines due to the emergence of new diseases.
Key Trends
The rise in infectious diseases and increase in demand for services in the biodefense market
Forensic Technology Market:
Differentiating Aspects
Forensic Technology Market
CAGR (2023 to 2033)
10.5%
Market Valuation in 2023
US$ 5.25 billion
Projected Market Value in 2033
US$ 14.25 billion
Growth Factors
Development of advanced technologies such as DNA analysis etc.
Opportunities
The expansion of forensic services creates opportunities for companies to expand their businesses.
Key Trends
Rise in crime rates and government initiatives to improve criminal investigations.
Biosensors Market:
Differentiating Aspects
Biosensors Market
CAGR (2023 to 2033)
8.1%
Market Valuation in 2023
US$ 29.1 billion
Projected Market Value in 2033
US$ 63.40 billion
Growth Factors
Increase in demand for quick and convenient medical testing.
Opportunities
Increasing demand for remote patient monitoring systems.
Key Trends
Development of new technologies like miniaturization, integration with wearables, and improved sensitivity.
Find your sweet spots for generating winning opportunities in this market.
Factors Driving the Biodefense Market
Rise in Technological Advancements
Due to the rise of bioterrorism, prominent industry players have incorporated advances in biothreat detection systems. These advances aid in the identification of bacteria and viruses that may be beneficial to market growth during the analysis period. As a result, technological breakthroughs can have a beneficial influence on market growth. To secure the security and safety of the population, technologically sophisticated biothreat detection technologies are necessary, which can help boost the market's growth.
To detect pathogens in nanotechnology, forensics, and biodefense-related drug development, innovative technologies, including gene chips, are widely used. As a means of improving agricultural yields, synthetic biology is also contributing to market growth, as it improves agricultural yields.
Increase in Investments by Government for Defense Expenditure
It is one of the key factors driving the growth of the market that the threat of terrorism is growing along with an ever-increasing level of tension between nations. It is also contributing to biodefense market growth that governments across several nations are increasing their defense spending to improve both internal and external security.
For example, the United States Department of Defense (DoD) spent US$ 718 billion in FY 2021, with the large category being operation and maintenance at US$ 286 billion. Furthermore, government agencies are developing medical countermeasures for chemical, biological, nuclear, and radiological threats to minimize the adverse effects of these attacks.
The Rise in Demand for Vaccines
The development of novel vaccine technologies, such as vector technology, is expected to drive the growth of the biodefense market as they can provide rapid protection against pathogen attacks. In recent years, vaccines have been developed that can combat a wide variety of bioterrorism chemicals and can induce long-lasting immune responses.
Several countries are experiencing a surge in Ebola and Zika infections, resulting in a race to develop vaccines. The government spends a lot of money on vaccine research and development to make sure it is prepared for any bioterrorism attacks. Pharmaceutical companies operating in the biodefense market have a huge opportunity to expand since governments are always looking for ways to prevent bioterrorism.
Category-wise Insights
Product Insights: The Anthrax Segment isexpected to be the significant Contributor to the Market
In terms of products, the market is segmented into anthrax, smallpox, botulism, radiation/nuclear, and others. The anthrax segment held a prominent market share of 28.1% in 2023. Many factors contribute to the growth of the anthrax product segment. Some of these factors include the increase in anthrax outbreaks in humans, favorable government initiatives, and collaboration in research and development in the studied fields.
In July 2022, as reported by the media, 15 cases of cutaneous anthrax were linked to an anthrax outbreak in cattle in Sisak-Moslavina County following heavy rain, according to the European Centre for Disease Prevention and Control (ECDC) Communicable Disease Threat Report. Moreover, in July 2022, the Croatian Ministry of Agriculture issued an order containing measures to prevent the outbreak and spread of anthrax in the affected area. These measures include closures of affected areas, vaccinations of animals, and additional human prevention measures.
One of the most likely potential weapons used in a bioterrorist attack is Bacillus anthracis, a gram-positive bacterium that causes anthrax. Those spores are preferred because they can be easily released into the environment by adding them to food, water, powders, and sprays. The bacterium can persist in the environment for a long time and is easily found in nature (soil, plants, or water). As anthrax bacteria can be easily transmitted from one person to another, NCBI categorizes it as a tier-1 biological agent, which has the potential to cause a massive public health disaster.
In the field of countermeasures, anthrax remains a key focus. It has received a significant amount of funding for vaccine development. Many companies have developed anthrax vaccines, including Bioshield, which has received over US$ 50 billion in funding since the September 11 attacks.
In recent years, many countries have seen a rise in infection cases caused by the Zika virus and Ebola virus. This has prompted many companies to compete to develop vaccines for these viruses. MVA-BN Filo, manufactured by Bavarian Nordic, is a vaccine against two filoviruses, Ebola and Marburg's diseases, currently in phase 3 clinical trials and collaborating with the United States NIAID for the same.
Region Wise: North America Dominates the Market
In 2023, North America accounted for 79% of the biodefense market and is expected to exhibit a significant growth rate. As a result of federal funding, technological advancements, and growing awareness, this market is projected to expand significantly in the forecast period. Key players in this region make it easy for the biodefense market to grow in 2023. Increased research and development in the studies field, as well as increasing government initiatives, are the primary growth factors in this market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Regions Leading in Biodefense Market: Country-wise Analysis
The United States Biodefense Market Dominates North America Region
During the forthcoming years, the United States Biodefense Market is expected to dominate North America due to the growing importance of biodefense and increasing threats from harmful biological materials. Furthermore, the United States has well-established vaccine production facilities and is one of the region's most developed biodefense markets. Moreover, the United States government implements some initiatives that help them strengthen security against bioterrorism attacks. For example, the government plans a pandemic influenza program and a program to fight infectious diseases.
The regional market forecast may also be influenced by other factors, such as the growing adoption of technologically advanced products and the increasing awareness of biodefense among individuals.
A leadership structure and a comprehensive strategy were established in National Security Presidential Memorandum 14 (NSPM-14) to coordinate all biodefense efforts associated with the U.S. Government. The combination of the strategy and memorandum enabled the annual budget planning process to identify and connect gaps for the first time.
Why is Germany’s Biodefense Market Considered Lucrative within Europe?
In Germany, biodefense products and services are manufactured and sold to protect against biological threats such as infectious diseases and bioterrorism. It consists of a wide range of products and services, including vaccinations, diagnostic tests, protective equipment, and decontamination systems.
Germany is considered a leading player in the global biodefense market. This is because it has a strong presence of multinational corporations and government institutions involved in research and development, as well as the production and distribution of biodefense products. The government of Germany has also made significant investments in the biodefense sector, which has helped to spur growth and innovation in the market.
Overall, the biodefense market in Germany is expected to continue growing in the coming years. This is driven by factors such as increasing concerns about global pandemics, bioterrorism, and the growing threat of antimicrobial resistance.
What Makes China Biodefense Market Highly Attractive?
During the forecast period, China is expected to expand at the high rate of 8.8% due to surges in Research and development. Growing awareness of biodefense, as well as the threat of harmful biological materials that engender emergencies, can drive growth in the biodefense market.
A combination of this and a sophisticated healthcare infrastructure contributes to China's market position. In addition, China is vigorously expanding its research and development capabilities to meet future biological threats. After the United States, China spends the second highest percentage of its GDP on research and development. These factors are expected to boost China's biodefense industry.
Start-up Ecosystem
The biodefense market is home to several startups around the world. These startups are focused on developing innovative solutions to protect against biological threats, including infectious diseases and bioterrorism.
Some examples of Startups Operating in the Biodefense Market include:
BioMimetix JV, LLC: a company based in Germany develops biometric solutions for identifying and tracking infectious diseases.
BioDetectors: the United Kingdom-based startup that develops rapid diagnostic tests for the detection of biological threats.
PathAI: a company that uses artificial intelligence to improve the accuracy of disease diagnosis.
Tener Vaccines: Germany-based startup that focuses on the development of vaccines for the prevention of infectious diseases.
Takeda Pharmaceuticals: Japan-based pharmaceutical company that develops and sells vaccines and treatments for infectious diseases.
Biomatrica: the United States-based company that provides solutions for the preservation of biological samples for research and diagnostic purposes.
These startups are working on developing and commercializing cutting-edge technologies and products to address the challenges posed by biological threats. They play an influential role in driving innovation and growth in the biodefense market.
Competitive Landscape: Key Players Operating in the Market
In emerging and economically favorable regions, many of these players are notably collaborating with governments to gain bulk orders and boost sales. Many companies are partnering with each other to develop drugs so that they can introduce their products fast.
Key players operating in the Market:
XOMA Corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
SIGA Technologies
Elusys Therapeutics Inc
Ichor Medical Systems
Dynport Vaccine Company
Cleveland Biolabs
Bavarian Nordic
Ology Bioservices
Alnylam Pharmaceuticals Inc.
Recent Developments:
Key players are focusing on novel and innovative approaches for the development of new Biodefenses. The strategy of expansion, new product launches, and approvals, by key manufacturers, are crucial strategies for further strengthening the presence of market players and allowing them to stay ahead of the competition.
Appili Therapeutics Inc. announced funding of over US$ 10 million in February 2022 to advance its biodefense vaccine candidate, ATI-1701, to prevent infection with Francisella tularensis. This funding is expected to boost the company's presence and boost growth in the biodefense market.
It was reported that Emergent BioSolutions Inc. (NYSE: EBS) has received approval for the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) from the United States Food and Drug Administration (FDA).
It was announced in May 2022 that Emergent BioSolutions Inc. had signed a definitive agreement with Chimerix, Inc. to acquire Chimerix's exclusive worldwide rights to TEMBEXA (brincidofovir), the first antiviral approved by the United States Food and Drug Administration (FDA) to treat smallpox in all age groups.
The privately held company Ichor Medical Systems, Inc., announced in March 2019 that it collaborated with AstraZeneca for the development and clinical assessment of plasmid DNA constructs (recombinant monoclonal antibodies). Aside from upfront and annual payments, Ichor may also be paid development milestones under the terms of the agreement.
CEPI (the Coalition for Epidemic Preparedness Innovations) entered into a collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc., in August 2018, to manufacture a vaccine against the Lassa virus. Through this collaboration, companies were able to expand their product portfolio.
Scope of Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2023
Market Analysis
US$ million for Value and MT for Volume
Key Regions Covered
North America
Latin America
Europe
The Middle East and Africa
East Asia
Key Countries Covered
United States, Canada, Brazil, Mexico, Chile, Peru, Germany, United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Türkiye
Key Segments Covered
ProductProduct
Region
Key Companies Profiled
XOMA Corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
SIGA Technologies
Elusys Therapeutics Inc
Ichor Medical Systems
Dynport Vaccine Company
Cleveland Biolabs
Bavarian Nordic
Ology Bioservices
Alnylam Pharmaceuticals Inc.
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Biodefense Market Segmentation by Category
By Product:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
By Region Outlook:
North America
Latin America
Europe
The Middle East and Africa
East Asia
Frequently Asked Questions
What is the Current Valuation of the Biodefense Market?
The valuation of the biodefense market reaches a notable sum of US$ 16.31 billion in 2023.
What is the Estimated Biodefense Market Size Envisioned by 2033?
The biodefense market is estimated to achieve a valuation of US$ 32.99 billion by 2033.
What CAGR is Foreseen for the Biodefense Market in the Upcoming Decade?
The biodefense market is poised to witness a 7.3% CAGR through 2033.
Which is the Top Trend in the Biodefense Market?
Advanced detection technologies stand out as the top trend in the biodefense market.
Which is the Key Segment in the Biodefense Market by Product Type?
The anthrax segment is positioned to sustain its preference in the market through 2033, holding a 28.1% share.
Table of Content
1. Executive Summary | Biodefense Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Anthrax Biodefense
5.3.2. Botulism Biodefense
5.3.3. Smallpox Biodefense
5.3.4. Cholera Biodefense
5.3.5. Influenza Biodefense
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
6.3.1. Hospitals and Clinics
6.3.2. Ambulatory Care Centres
6.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By End-User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By End-User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Type
9.2.3. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By End-User
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Type
10.2.3. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By End-User
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Type
11.2.3. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By End-User
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type
12.2.3. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By End-User
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Type
13.2.3. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By End-User
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Type
14.2.3. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By End-User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By End-User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By End-User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By End-User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By End-User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By End-User
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By End-User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By End-User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By End-User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By End-User
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By End-User
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By End-User
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By End-User
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By End-User
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By End-User
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By End-User
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Type
15.16.2.2. By End-User
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Type
15.17.2.2. By End-User
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Type
15.18.2.2. By End-User
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Type
15.19.2.2. By End-User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Type
15.20.2.2. By End-User
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Type
15.21.2.2. By End-User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By End-User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. XOMA corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Altimmune Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Emergent Biosolutions Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Dynavax Technologies Corporation.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. SIGA Technologies.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Elusys Therapeutics Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Ichor Medical Systems.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Dynport Vaccine Company.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Cleveland Biolabs.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Bavarian Nordic.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Ology Bioservices.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Alnylam Pharmaceuticals Inc
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: South Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 15: South Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 18: East Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Oceania Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 21: Oceania Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End-User, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 13: Global Market Attractiveness by Type, 2023 to 2033
Figure 14: Global Market Attractiveness by End-User, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 28: North America Market Attractiveness by Type, 2023 to 2033
Figure 29: North America Market Attractiveness by End-User, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End-User, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Type, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by End-User, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 58: Europe Market Attractiveness by Type, 2023 to 2033
Figure 59: Europe Market Attractiveness by End-User, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: South Asia Market Value (US$ Million) by Type, 2023 to 2033
Figure 62: South Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: South Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 70: South Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 71: South Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 73: South Asia Market Attractiveness by Type, 2023 to 2033
Figure 74: South Asia Market Attractiveness by End-User, 2023 to 2033
Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 76: East Asia Market Value (US$ Million) by Type, 2023 to 2033
Figure 77: East Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 85: East Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 88: East Asia Market Attractiveness by Type, 2023 to 2033
Figure 89: East Asia Market Attractiveness by End-User, 2023 to 2033
Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 91: Oceania Market Value (US$ Million) by Type, 2023 to 2033
Figure 92: Oceania Market Value (US$ Million) by End-User, 2023 to 2033
Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: Oceania Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 100: Oceania Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 103: Oceania Market Attractiveness by Type, 2023 to 2033
Figure 104: Oceania Market Attractiveness by End-User, 2023 to 2033
Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 106: MEA Market Value (US$ Million) by Type, 2023 to 2033
Figure 107: MEA Market Value (US$ Million) by End-User, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: MEA Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 113: MEA Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 115: MEA Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 116: MEA Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 118: MEA Market Attractiveness by Type, 2023 to 2033
Figure 119: MEA Market Attractiveness by End-User, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
